Immunomodulators heighten risk for high-grade cervical neoplasia, cancer in women with IBD

Cumulative exposure to immunomodulators increased the risk for high-grade cervical intraepithelial neoplasia and cervical cancer in women with inflammatory bowel disease, according to data from Alimentary Pharmacology & Therapeutics.“There is growing evidence that cervical neoplasia risk is increased in women with IBD,” Joany E. Kreijne, MD, from the department of gastroenterology and hepatology at Erasmus University Medical Center, and colleagues wrote. “Immunosuppressive drugs may be involved in induction of carcinogenesis and accelerated progression throughRead More